Highlights from EHA/ICML 2025: International Perspective on CLL
In this podcast episode, we discuss clinical trial updates in chronic lymphocytic leukemia from the 2025 European Hematology Association annual congress in Milan, Italy and the 18th International Conference on Malignant Lymphoma in Lugano, Switzerland. The discussion involves an analysis of the da…
Passing Parade with John Gribben
This interview first aired on ONE FM 98.5 Shepparton.
One FM announcer Roman 'Koz' Kozlovski interviews Euroa resident and local historian John Gribben for his weekly program 'The Passing Parade".
This program first aired on Friday the 4th of July, 2025.
Listen to Roman Koz on Friday Mornings f…
Thanksforyourservice Podcast 82 - WW2 PoW and Internee camps in the Goulburn Valley, Victoria
Welcome to our 82nd podcast for Thanks for your Service.
Our focus is on historical topics relating to the Australian military.
You can find us on Facebook, X and Youtube. Just search for Thanks For Your Service. Our website is www.thanksforyourservice.net . You can also email us at info@tha…
Setting the Standard for Quality Care in Hematologic Malignancies (with Prof John Gribben)
Join us for this discussion between Robin Doeswijk, EHA European Affairs and prof. John Gribben from Barts Cancer Institute in the United Kingdom on the topic of equity in care of patients with hematologic malignancies.
This discussion follows the recently published “European Cancer Organisation …
iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as they discussed the latest clinical updates in the field. In this podcast series, you will hear the latest advances in the treatment and management of lymphoma and g…
iwCAR-T Session IV: CAR-T therapy in CLL: challenges, combination approaches and ongoing trials
The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this …
The current status of CAR-T therapy in CLL and challenges in this space
In recent years, novel immunotherapies, including CAR-T cell therapy, have greatly improved treatment options for patients with hematological malignancies. Although CAR-T cells have demonstrated remarkable success in several diseases, including multiple myeloma, acute lymphoblastic leukemia (ALL),…
iwNHL Session II: Understanding and harnessing the immune microenvironment against lymphoma
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in the field as they discussed several topics. In this podcast series, you will hear the latest updates in NHL and gain an insight into the sessions that took p…
The promise of CAR-T therapy in CLL and challenges in the field
The treatment landscape of chronic lymphocytic leukemia (CLL) has greatly transformed over the years with the introduction of several agents, including Bruton's tyrosine kinase (BTK) inhibitors, the BCL-2 inhibitor venetoclax, and anti-CD20 antibodies. CAR-T cell therapy has also improved treatmen…
מנוע חיפוש PODCAST
אתה יכול להשתמש באתר שלנו כדי לחפש3,825,360פודקאסטים ופודקאסטים195,862,401לפי אנשים, מקומות או נושאים.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
